15 November 2018 - - US-based clinical-stage immunotherapy company Harpoon Therapeutics, Inc has closed a USD 70m Series C equity financing, the company said.

OrbiMed served as the lead new investor, along with new investors Cormorant, R...
15 November 2018 - - Chinese biopharmaceutical company Generon Corp has received approval for the company's Investigational New Drug application from the State Food and Drug Administration of the People's Republic of China to initiate ...
15 November 2018 - - Anglo-Swedish pharmaceutical company AstraZeneca (OTC: AZNCF) has received positive full results from the DECLARE-TIMI 58 cardiovascular outcomes trial for Farxiga (dapagliflozin), the company said.

The data were pre...
15 November 2018 - - US-based biopharmaceutical company Brooklyn ImmunoTherapeutics presented the clinical results of IRX-2 therapy in resectable breast cancer and head and neck cancer that were presented in an oral presentation at the 2018 annual me...
15 November 2018 - - US-based Arixa Pharmaceuticals, Inc., a developer of oral antibiotics for drug-resistant Gram-negative infections, has published a paper describing the chemistry of its oral prodrug of avibactam, a previously intravenous -only be...